Filing search / Tempest Therapeutics, Inc. / "Death" / Page 7

424B5

zq8dki 3w

8 Jan 15

Prospectus supplement for primary offering

12:00am

8-K

EX-1.1

betl2 rdc

8 Jan 15

Entry into a Material Definitive Agreement

12:00am

424B5

jsz wysvkj

6 Jan 15

Prospectus supplement for primary offering

12:00am

8-K

EX-10.1

ekacq4j8zm8xjwmi92jv

18 Sep 14

OvaScience Appoints Jeffrey Young to Chief Financial Officer

12:00am

424B2

aaoz7 8sezwu67

5 Mar 14

Prospectus for primary offering

12:00am

424B5

k807c

3 Mar 14

Prospectus supplement for primary offering

12:00am

424B3

j3l0vegyaaku52bv

3 May 13

Prospectus supplement

12:00am

10-K

EX-10.26

xgtqcqdlw

25 Feb 13

Annual report

12:00am